Aron Lichtman

Research Profile

Living Beings

Chemicals & Drugs

Concepts & Ideas

Drug Dose Response Relationship

Physiology

Maze Learning

Co-author Network

Publications

TOP 3
Lamont Booker; Steven G Kinsey; Rehab A Abdullah; Jacqueline L Blankman; Jonathan Z Long; Cyrine Ezzili; Dale L Boger; Benjamin F Cravatt; Aron H Lichtman
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
Sándor Bátkai; Partha Mukhopadhyay; Bėla Horváth; Mohanraj Rajesh; Rachel Y Gao; Anu Mahadevan; Mukkanti Amere; Natalia Battista; Aron H Lichtman; Lisa A Gauson; et al.
Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
Erik B Oleson; Michael V Beckert; Joshua T Morra; Carien S Lansink; Roger Cachope; Rehab A Abdullah; Amy L Loriaux; Dustin Schetters; Tommy Pattij; Mitchell F Roitman; et al.
Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Aron Lichtman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Lamont Booker; Steven G Kinsey; Rehab A Abdullah; Jacqueline L Blankman; Jonathan Z Long; Cyrine Ezzili; Dale L Boger; Benjamin F Cravatt; Aron H Lichtman
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
British journal of pharmacology 2012;165(8):2485-96.
2012: Sándor Bátkai; Partha Mukhopadhyay; Bėla Horváth; Mohanraj Rajesh; Rachel Y Gao; Anu Mahadevan; Mukkanti Amere; Natalia Battista; Aron H Lichtman; Lisa A Gauson; et al.
Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
British journal of pharmacology 2012;165(8):2450-61.
2012: Erik B Oleson; Michael V Beckert; Joshua T Morra; Carien S Lansink; Roger Cachope; Rehab A Abdullah; Amy L Loriaux; Dustin Schetters; Tommy Pattij; Mitchell F Roitman; et al.
Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum.
Neuron 2012;73(2):360-73.
2012: Thomas F Gamage; Aron H Lichtman
The endocannabinoid system: role in energy regulation.
Pediatric blood & cancer 2012;58(1):144-8.
2011: Daniel K Nomura; Bradley E Morrison; Jacqueline L Blankman; Jonathan Z Long; Steven G Kinsey; Maria Cecilia G Marcondes; Anna M Ward; Yun Kyung Hahn; Aron H Lichtman; Bruno Conti; et al.
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation.
Science (New York, N.Y.) 2011;334(6057):809-13.
2011: Steven G Kinsey; Pattipati S Naidu; Benjamin F Cravatt; David T Dudley; Aron H Lichtman
Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice.
Pharmacology, biochemistry, and behavior 2011;99(4):718-25.
2011: Divya Ramesh; Gracious R Ross; Joel E Schlosburg; Robert A Owens; Rehab A Abdullah; Steven G Kinsey; Jonathan Z Long; Daniel K Nomura; Laura J Sim-Selley; Benjamin F Cravatt; et al.
Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
The Journal of pharmacology and experimental therapeutics 2011;339(1):173-85.
2011: Laura E Wise; Stephen A Varvel; Dana E Selley; Jason M Wiebelhaus; Kelly A Long; Lisa S Middleton; Laura J Sim-Selley; Aron H Lichtman
delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory.
Psychopharmacology 2011;217(4):485-94.
2011: Steven G Kinsey; Daniel K Nomura; Scott T O'Neal; Jonathan Z Long; Anu Mahadevan; Benjamin F Cravatt; John R Grider; Aron H Lichtman
Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.
The Journal of pharmacology and experimental therapeutics 2011;338(3):795-802.
2011: Joel E Schlosburg; Scott T O'Neal; Daniel H Conrad; Aron H Lichtman
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.
Psychopharmacology 2011;216(3):323-31.
2011: Yosefa Avraham; Mayer Saidian; James J Burston; Raphael Mevorach; Lia Vorobiev; Iddo Magen; Eithan Kunkes; Beatriz Borges; Aron H Lichtman; Elliot M Berry
Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals.
The Journal of nutritional biochemistry 2011;22(8):766-76.
2011: Aron H Lichtman; Victoria Chapman
A FAAH-fetched approach to treat osteoarthritis pain.
Pain 2011;152(5):959-60.
2011: Cyrine Ezzili; Mauro Mileni; Nicholas McGlinchey; Jonathan Z Long; Steven G Kinsey; Dustin G Hochstatter; Raymond C Stevens; Aron H Lichtman; Benjamin F Cravatt; Edward J Bilsky; et al.
Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.
Journal of medicinal chemistry 2011;54(8):2805-22.
2011: Steven G Kinsey; Scott T O'Neal; Jonathan Z Long; Benjamin F Cravatt; Aron H Lichtman
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
Pharmacology, biochemistry, and behavior 2011;98(1):21-7.
2011: Steven G Kinsey; Anu Mahadevan; Bingjun Zhao; Hang Sun; Pattipati S Naidu; Raj K Razdan; Dana E Selley; M Imad Damaj; Aron H Lichtman
The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects.
Neuropharmacology 2011;60(2-3):244-51.
2011: Ken Soderstrom; Justin L Poklis; Aron H Lichtman
Cannabinoid exposure during zebra finch sensorimotor vocal learning persistently alters expression of endocannabinoid signaling elements and acute agonist responsiveness.
BMC neuroscience 2011;12():3.
2010: Aron H Lichtman; Jacqueline L Blankman; Benjamin F Cravatt
Endocannabinoid overload.
Molecular pharmacology 2010;78(6):993-5.
2010: Steven G Kinsey; Jonathan Z Long; Benjamin F Cravatt; Aron H Lichtman
Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms.
The journal of pain : official journal of the American Pain Society 2010;11(12):1420-8.
2010: Gerald T DeLong; Carl E Wolf; Alphonse Poklis; Aron H Lichtman
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
Drug and alcohol dependence 2010;112(1-2):126-33.
2010: Justin L Poklis; Candace C Thompson; Kelly A Long; Aron H Lichtman; Alphonse Poklis
Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry.
Journal of analytical toxicology 2010;34(8):516-20.
2010: Joel E Schlosburg; Jacqueline L Blankman; Jonathan Z Long; Daniel K Nomura; Bin Pan; Steven G Kinsey; Peter T Nguyen; Divya Ramesh; Lamont Booker; James J Burston; et al.
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system.
Nature neuroscience 2010;13(9):1113-9.
2010: Pattipati S Naidu; Steven G Kinsey; Tai L Guo; Benjamin F Cravatt; Aron H Lichtman
Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
The Journal of pharmacology and experimental therapeutics 2010;334(1):182-90.
2010: Katherine W Falenski; Andrew J Thorpe; Joel E Schlosburg; Benjamin F Cravatt; Rehab A Abdullah; Tricia H Smith; Dana E Selley; Aron H Lichtman; Laura J Sim-Selley
FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(8):1775-87.
2009: Jonathan Z Long; Daniel K Nomura; Robert E Vann; D Matthew Walentiny; Lamont Booker; Xin Jin; James J Burston; Laura J Sim-Selley; Aron H Lichtman; Jenny L Wiley; et al.
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(48):20270-5.
2009: Lamont Booker; Pattipati S Naidu; Raj K Razdan; Anu Mahadevan; Aron H Lichtman
Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
Drug and alcohol dependence 2009;105(1-2):42-7.
2009: Laura E Wise; John P Harloe; Aron H Lichtman
Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task.
Neurobiology of learning and memory 2009;92(4):597-601.
2009: S G Kinsey; J Z Long; S T O'Neal; R A Abdullah; J L Poklis; D L Boger; B F Cravatt; A H Lichtman
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
The Journal of pharmacology and experimental therapeutics 2009;330(3):902-10.
2009: Laura E Wise; Andrew J Thorpe; Aron H Lichtman
Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(9):2072-80.
2009: Joel E Schlosburg; Brittany L A Carlson; Divya Ramesh; Rehab A Abdullah; Jonathan Z Long; Benjamin F Cravatt; Aron H Lichtman
Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice.
The AAPS journal 2009;11(2):342-52.
2009: Joel E Schlosburg; Dale L Boger; Benjamin F Cravatt; Aron H Lichtman
Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus.
The Journal of pharmacology and experimental therapeutics 2009;329(1):314-23.
2009: Pattipati S Naidu; Lamont Booker; Benjamin F Cravatt; Aron H Lichtman
Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
The Journal of pharmacology and experimental therapeutics 2009;329(1):48-56.
2009: Joel E Schlosburg; Steven G Kinsey; Aron H Lichtman
Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
The AAPS journal 2009;11(1):39-44.
2008: Daniel K Nomura; Carolyn S S Hudak; Anna M Ward; James J Burston; Roger S Issa; Karl J Fisher; Mary E Abood; Jenny L Wiley; Aron H Lichtman; John E Casida
Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels.
Bioorganic & medicinal chemistry letters 2008;18(22):5875-8.
2008: John P Harloe; Andrew J Thorpe; Aron H Lichtman
Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasks.
Learning & memory (Cold Spring Harbor, N.Y.) 2008;15(11):806-9.
2008: Laura E Wise; Philip A Iredale; Aron H Lichtman
The cannabinoid CB(1) receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task.
European journal of pharmacology 2008;590(1-3):246-9.
2008: Lisa L Merritt; B R Martin; C Walters; A H Lichtman; M Imad Damaj
The endogenous cannabinoid system modulates nicotine reward and dependence.
The Journal of pharmacology and experimental therapeutics 2008;326(2):483-92.
2008: Matt H Oltmanns; Sandeep S Samudre; Ivan G Castillo; Alireza Hosseini; Aron H Lichtman; Robert C Allen; Frank A Lattanzio; Patricia B Williams
Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2008;24(1):104-15.
2008: Laura E Wise; Roberta Cannavacciulo; Benjamin F Cravatt; Billy F Martin; Aron H Lichtman
Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
Neuropharmacology 2008;54(1):181-8.
2007: Laura E Wise; Aron H Lichtman
The uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist memantine prolongs spatial memory in a rat delayed radial-arm maze memory task.
European journal of pharmacology 2007;575(1-3):98-102.
2007: Floride Niyuhire; Stephen A Varvel; Billy R Martin; Aron H Lichtman
Exposure to marijuana smoke impairs memory retrieval in mice.
The Journal of pharmacology and experimental therapeutics 2007;322(3):1067-75.
2007: Stephen A Varvel; Billy R Martin; Aron H Lichtman
Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine.
Psychopharmacology 2007;193(4):511-9.
2007: Laura E Wise; Philip A Iredale; Rene J Stokes; Aron H Lichtman
Combination of rimonabant and donepezil prolongs spatial memory duration.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(8):1805-12.
2007: Pattipati S Naidu; Aron H Lichtman; Carey C Archer; Everett L May; Louis S Harris; Mario D Aceto
NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action.
European journal of pharmacology 2007;566(1-3):132-6.
2007: Pattipati S Naidu; Stephen A Varvel; Kyunghye Ahn; Benjamin F Cravatt; Billy R Martin; Aron H Lichtman
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
Psychopharmacology 2007;192(1):61-70.
2007: Stephen A Varvel; Laura E Wise; Floride Niyuhire; Benjamin F Cravatt; Aron H Lichtman
Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(5):1032-41.
2007: Floride Niyuhire; Stephen A Varvel; Andrew J Thorpe; Rene J Stokes; Jenny L Wiley; Aron H Lichtman
The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific.
Psychopharmacology 2007;191(2):223-31.
2007: R G Pertwee; A Thomas; L A Stevenson; R A Ross; S A Varvel; A H Lichtman; B R Martin; R K Razdan
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
British journal of pharmacology 2007;150(5):586-94.
2007: Laura E Wise; Christopher C Shelton; Benjamin F Cravatt; Billy R Martin; Aron H Lichtman
Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.
European journal of pharmacology 2007;557(1):44-8.
2007: Alexander F Hoffman; Murat Oz; Ruiqin Yang; Aron H Lichtman; Carl R Lupica
Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
Learning & memory (Cold Spring Harbor, N.Y.) 2007;14(1-2):63-74.
2006: David M Wilson; Stephan A Varvel; John P Harloe; Billy R Martin; Aron H Lichtman
SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice.
Pharmacology, biochemistry, and behavior 2006;85(1):105-13.
2006: S A Varvel; J L Wiley; R Yang; D T Bridgen; K Long; A H Lichtman; B R Martin
Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
Psychopharmacology 2006;186(2):226-34.
2006: Stephen A Varvel; Benjamin F Cravatt; April E Engram; Aron H Lichtman
Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task.
The Journal of pharmacology and experimental therapeutics 2006;317(1):251-7.
2005: S A Varvel; D T Bridgen; Q Tao; B F Thomas; B R Martin; A H Lichtman
Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
The Journal of pharmacology and experimental therapeutics 2005;314(1):329-37.
2005: S A Varvel; E A Anum; A H Lichtman
Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice.
Psychopharmacology 2005;179(4):863-72.
2005: Aron H Lichtman; Benjamin F Cravatt
Food for thought: endocannabinoid modulation of lipogenesis.
The Journal of clinical investigation 2005;115(5):1130-3.
2005: S A Varvel; E Anum; F Niyuhire; L E Wise; A H Lichtman
Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline.
Psychopharmacology 2005;178(2-3):317-27.
2005: A H Lichtman; B R Martin
Cannabinoid tolerance and dependence.
Handbook of experimental pharmacology 2005;(168):691-717.
2004: Aron H Lichtman; Donmienne Leung; Christopher C Shelton; Alan Saghatelian; Christophe Hardouin; Dale L Boger; Benjamin F Cravatt
Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity.
The Journal of pharmacology and experimental therapeutics 2004;311(2):441-8.
2004: Benjamin F Cravatt; Aron H Lichtman
The endogenous cannabinoid system and its role in nociceptive behavior.
Journal of neurobiology 2004;61(1):149-60.
2004: Benjamin F Cravatt; Alan Saghatelian; Edward G Hawkins; Angela B Clement; Michael H Bracey; Aron H Lichtman
Functional disassociation of the central and peripheral fatty acid amide signaling systems.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(29):10821-6.
2004: Aron H Lichtman; Christopher C Shelton; Tushar Advani; Benjamin F Cravatt
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
Pain 2004;109(3):319-27.
2003: Benjamin F Cravatt; Aron H Lichtman
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
Current opinion in chemical biology 2003;7(4):469-75.
2003: Angela B Clement; E Gregory Hawkins; Aron H Lichtman; Benjamin F Cravatt
Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(9):3916-23.
2002: Benjamin F Cravatt; Aron H Lichtman
The enzymatic inactivation of the fatty acid amide class of signaling lipids.
Chemistry and physics of lipids 2002;121(1-2):135-48.
2002: Aron H Lichtman; Billy R Martin
Marijuana withdrawal syndrome in the animal model.
Journal of clinical pharmacology 2002;42(11 Suppl):20S-27S.
2002: David M Wilson; Joanne Peart; Billy R Martin; D Troy Bridgen; Peter R Byron; Aron H Lichtman
Physiochemical and pharmacological characterization of a Delta(9)-THC aerosol generated by a metered dose inhaler.
Drug and alcohol dependence 2002;67(3):259-67.
2002: Aron H Lichtman; E Gregory Hawkins; Graeme Griffin; Benjamin F Cravatt
Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
The Journal of pharmacology and experimental therapeutics 2002;302(1):73-9.
2002: S A Varvel; Aron H Lichtman
Evaluation of CB1 receptor knockout mice in the Morris water maze.
The Journal of pharmacology and experimental therapeutics 2002;301(3):915-24.
2002: A H Lichtman; S A Varvel; B R Martin
Endocannabinoids in cognition and dependence.
Prostaglandins, leukotrienes, and essential fatty acids 2002;66(2-3):269-85.
2001: C L O'Neal; A Poklis; A H Lichtman
Acetylcodeine, an impurity of illicitly manufactured heroin, elicits convulsions, antinociception, and locomotor stimulation in mice.
Drug and alcohol dependence 2001;65(1):37-43.
2001: S A Varvel; R J Hamm; B R Martin; A H Lichtman
Differential effects of delta 9-THC on spatial reference and working memory in mice.
Psychopharmacology 2001;157(2):142-50.
2001: A H Lichtman; S M Sheikh; H H Loh; B R Martin
Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
The Journal of pharmacology and experimental therapeutics 2001;298(3):1007-14.
2001: B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(16):9371-6.
2001: A H Lichtman; J L Poklis; A Poklis; D M Wilson; B R Martin
The pharmacological activity of inhalation exposure to marijuana smoke in mice.
Drug and alcohol dependence 2001;63(2):107-16.
2001: A H Lichtman; J Fisher; B R Martin
Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
Pharmacology, biochemistry, and behavior 2001;69(1-2):181-8.
2000: A H Lichtman
SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats.
European journal of pharmacology 2000;404(1-2):175-9.
2000: A H Lichtman; J Peart; J L Poklis; D T Bridgen; R K Razdan; D M Wilson; A Poklis; Y Meng; P R Byron; B R Martin
Pharmacological evaluation of aerosolized cannabinoids in mice.
European journal of pharmacology 2000;399(2-3):141-9.
1999: Y Meng; M Dukat; D T Bridgen; B R Martin; A H Lichtman
Pharmacological effects of methamphetamine and other stimulants via inhalation exposure.
Drug and alcohol dependence 1999;53(2):111-20.
1998: B R Martin; A H Lichtman
Cannabinoid transmission and pain perception.
Neurobiology of disease 1998;5(6 Pt B):447-61.
1998: A H Lichtman; J L Wiley; K L LaVecchia; S T Neviaser; D B Arthur; D M Wilson; B R Martin
Effects of SR 141716A after acute or chronic cannabinoid administration in dogs.
European journal of pharmacology 1998;357(2-3):139-48.
1997: A H Lichtman; B R Martin
The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats.
Pharmacology, biochemistry, and behavior 1997;57(1-2):7-12.
1997: Y Meng; A H Lichtman; D T Bridgen; B R Martin
Inhalation studies with drugs of abuse.
NIDA research monograph 1997;173():201-24.
1996: Y Meng; A H Lichtman; D T Bridgen; B R Martin
Pharmacological potency and biodisposition of phencyclidine via inhalation exposure in mice.
Drug and alcohol dependence 1996;43(1-2):13-22.
1996: A H Lichtman; Y Meng; B R Martin
Inhalation exposure to volatilized opioids produces antinociception in mice.
The Journal of pharmacology and experimental therapeutics 1996;279(1):69-76.
1996: A H Lichtman; B R Martin
Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
Psychopharmacology 1996;126(2):125-31.
1996: A H Lichtman; S A Cook; B R Martin
Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.
The Journal of pharmacology and experimental therapeutics 1996;276(2):585-93.
1996: J L Wiley; D R Compton; P M Gordon; C Siegel; M Singer; A Dutta; A H Lichtman; R L Balster; R K Razdan; B R Martin
Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
Neuropharmacology 1996;35(12):1793-804.
1995: K A Moore; A H Lichtman; A Poklis; J F Borzelleca
alpha-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: pharmacological evaluation and interaction with methamphetamine.
Drug and alcohol dependence 1995;39(2):83-9.
1995: A H Lichtman; K R Dimen; B R Martin
Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats.
Psychopharmacology 1995;119(3):282-90.
1995: A H Lichtman; P Sathe; K R Dimen; B R Martin
Acute tolerance to the cardiovascular effects of volatilized cocaine free base in rats.
Drug and alcohol dependence 1995;38(3):247-54.
1995: S A Cook; S P Welch; A H Lichtman; B R Martin
Evaluation of cAMP involvement in cannabinoid-induced antinociception.
Life sciences 1995;56(23-24):2049-56.
1993: A H Lichtman; F L Smith; B R Martin
Evidence that the antinociceptive tail-flick response is produced independently from changes in either tail-skin temperature or core temperature.
Pain 1993;55(3):283-95.
1992: A H Lichtman; P B Smith; B R Martin
The antinociceptive effects of intrathecally administered cannabinoids are influenced by lipophilicity.
Pain 1992;51(1):19-26.
1991: A H Lichtman; B R Martin
Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism.
Brain research 1991;559(2):309-14.
1991: A H Lichtman; B R Martin
Spinal and supraspinal components of cannabinoid-induced antinociception.
The Journal of pharmacology and experimental therapeutics 1991;258(2):517-23.
1990: A H Lichtman; B R Martin
Spinal action of cannabinoid-induced antinociception.
NIDA research monograph 1990;105():422-4.